In a patient with bipolar disorder who is already on a therapeutic mood stabilizer, should the mood stabilizer be continued to prevent manic episodes and avoid antidepressant monotherapy due to the risk of triggering mania?

Yes, This Statement is Correct

The statement is accurate: patients with bipolar disorder should continue their mood stabilizer to prevent manic episodes and must not be treated with antidepressant monotherapy due to the substantial risk of triggering mania. 1, 2

Core Principle: Never Use Antidepressant Monotherapy in Bipolar Disorder

The evidence is unequivocal on this point. Antidepressants used alone in bipolar disorder carry a 2.83-fold increased risk of inducing mania 3. This risk is eliminated when antidepressants are combined with a mood stabilizer (hazard ratio 0.79, no increased risk) 3.

The Evidence Base

Guidelines explicitly state that antidepressants may only be used as adjuncts for depression "as long as the patient is also taking at least one mood stabilizer" 1. The WHO guidelines reinforce this, specifying that antidepressants in bipolar depression must "always be in combination with a mood stabilizer (lithium or valproate)" 2.

The rationale is clear:

• Antidepressants can destabilize mood or incite manic episodes 1
• Monotherapy with antidepressants is explicitly contraindicated in bipolar I disorder 4
• Even in bipolar depression with concurrent manic symptoms, antidepressants neither hasten recovery nor improve outcomes compared to mood stabilizers alone, but do increase manic symptom severity 5

Maintenance Therapy is Essential

Most patients with bipolar disorder require ongoing medication therapy to prevent relapse, with some needing lifelong treatment 1. The data supporting this are compelling:

• Over 90% of adolescents noncompliant with lithium relapsed within 18 months, compared to 37.5% who remained compliant 1
• Maintenance treatment should continue for at least 2 years after the last episode 2
• The regimen that stabilizes acute mania should be maintained for 12-24 months minimum 1

Approved Mood Stabilizers for Maintenance

Lithium and valproate are first-line for maintenance treatment 2. Additional FDA-approved options include:

• Lithium (approved down to age 12 for acute mania and maintenance) 1
• Lamotrigine and olanzapine (approved for maintenance in adults) 1

Clinical Algorithm for Antidepressant Use

If a patient with bipolar disorder requires treatment for depression:

1. First, ensure adequate mood stabilizer coverage (lithium, valproate, or lamotrigine at therapeutic doses)
2. Only then consider adding an antidepressant if depressive symptoms persist
3. Prefer SSRIs over tricyclic antidepressants (lower switch risk) 2
4. Use moderate doses for limited duration 6
5. Monitor closely for manic switch, irritability, or mood destabilization 1

Critical Caveat

For bipolar I disorder with mixed features or concurrent manic symptoms, do not add antidepressants at all 4, 5. In these scenarios, antidepressants worsen manic symptoms without improving depression 5.

The Consequences of Discontinuation

Withdrawal of mood stabilizers dramatically increases relapse risk, particularly within the first 6 months 1. Any attempt to discontinue prophylactic therapy must be:

• Done gradually
• With close monitoring for relapse
• After thorough patient/family education about early warning signs
• With diagnostic status reviewed to ensure continued treatment is justified 1

The bottom line: Your statement correctly identifies two fundamental principles of bipolar disorder management that are supported by both guideline recommendations and high-quality research evidence.